P2 Intravenous ferric carboxymaltose for the treatment of refractory restless leg syndrome

Abstract

modalities and the occurrence pre and post GH therapy is shown (figure 2). Discussion This study shows the high prevalence of SDB in children with PWS and treatment interventions used. The risk of OSA development post-GH initiation demonstrates the importance of CRSS. As treatment options involve long term NIV, CRSS should play a major role in monitoring PWS patients over time.